Asthma And Alcohol Consumption

Asthma is a chronic condition which causes a sudden inflammation and narrowing of airways in the...

The Acceleration of Spirits Aging Using Ultrasound

Bourbon, brandy and whiskey are all examples of alcoholic beverages which after fermentation and...

The Alarming Decline In Avian Wildlife

     Habitat loss, climate change, unregulated harvest and pollution have all contributed...

User picture.
Scott BeersRSS Feed of this column.

BS Chemistry from University of Pittsburgh at Johnstown with minor in Biology (1984). PhD in Medicinal Chemistry from University of North Carolina at Chapel Hill 1988. Post doctoral work at the University... Read More »

Edwin Kim, M.D., and colleagues at the University of North Carolina at Chapel Hill have discovered a new and effective treatment for patients suffering from peanut allergy.

The treatment is called sublingual immunotherapy, or SLIT, and involves the administration of liquefied peanut protein under the patient’s tongue. This site of administration is as crucial as it is strategic for the vasculature here bypasses both the stomach, which could result in digestion of some or all of the protein, as well as the liver where the protein could be metabolized.

The advantage is that much less protein need be administered compared to other therapies. Indeed the initial dose is a miniscule 0.0002 mg!

     Porphyromonas gingivalis is the pathogen responsible for chronic periodontitis (CP) or gingivitis. A prospective observational study of patients with Alzheimer’s disease (AD) and active CP showed a notable decline in cognition (Alzheimer’s Disease Assessment Scale-Cognitive and Mini Mental State Examination scales) during a six month period compared to AD patients without active CP.

     Tyler Clites holds a BS in Biomedical and Mechanical Engineering from Harvard (2014) and a PhD from Harvard//MIT program in Health Sciences and Technology (2018). Presently he is a Post Doc in the Biomechatronics group at the MIT Media Lab where his research focuses on the development of novel techniques for limb amputation surgery with the goal of improving the connection between the biological body and a synthetic limb. The approach is known as the agonist-antagonist myoneural interface (AMI).

     Neuronal loss/destruction is the leading cause of symptoms in patients suffering from neural injury or neurodegenerative disorders.

Following neural insult astrocytes proliferate and become active glial cells to form glial scarring in order to protect neighboring tissue from further damage.
An interesting study examining the relationship between push-up capacity and incidence of cardiovascular disease (CVD) was recently published in JAMA Network Open .